AUSTRALIAN CANCER CARE NETWORK LAUNCHES TO LINK SERVICES TO POPULATION, CLINICIANS & RESEARCHERS
Aims to reduce health system disparities and tackle cancers with low survival rates
The landscape of cancer care in Australia is set to transform with the Australian Government launch in May 2024 of the Australian Comprehensive Cancer Network (ACCN) at the Innovations Showcase event, hosted by Cancer Australia in Sydney, Australia.
The ACCN is a nationally integrated system of cancer care, aimed at enhancing patient experiences and outcomes through coordinated and equitable access, by linking to comprehensive cancer services across Australia. Anchored by Comprehensive Cancer Centres (CCCs), the ACCN strives to deliver evidence-driven prevention, diagnosis, treatment, and support to all Australians affected by cancer.
Comprehensive Cancer Centres (CCCs) will serve as anchors in the ACCN, connecting various cancer control services nationwide. Through building partnerships and harnessing virtual connectivity, CCCs will collaborate with other cancer care centres, academic institutions, Aboriginal Community Controlled Health Services, regional hospitals and allied health services, among others.
While Australia has some of the world’s highest cancer survival rates, not all people experience equal outcomes. There are significant disparities in cancer outcomes for some populations, particularly affecting those in rural and remote regions, as well as Aboriginal and Torres Strait Islander communities.
The ACCN aims to address these disparities, emphasising coordinated and equitable access to comprehensive cancer services irrespective of where a person lives, and marking a significant milestone in the advancement of cancer care in Australia.
Australian Health Journal spoke with Professor Dorothy Keefe CEO, Cancer Australia on the ACCN launch and the network being a major milestone in the Australian Cancer Plan, which was launched at the end of 2023.
Participation in the ACCN is voluntary, with services committing to a set of standards focusing on comprehensive cancer care, equitable access, research excellence, data collection, workforce development, and network connectivity. Importantly, the ACCN will complement existing networks and alliances within the cancer care landscape, fostering collaboration and maximising resources.
All services and professionals involved in cancer care are encouraged to join the ACCN and contribute to this transformative initiative.
“As part of the implementation of the Australian Cancer Plan launched in November, the ACCN represents an essential stage towards achieving our goals of improving cancer outcomes and experiences for all Australians.”, says Professor Keefe.
She points out, “To achieve world class cancer outcomes for all Australians and realise the ambition of the Australian Cancer Plan, we need collective action from all sectors of health care to address issues that contribute to variation in cancer outcomes and experience.”
-
Redefining diversity in clinical trials
Ensuring inclusion, diversity, equity and patient input in the development of novel drugs and medical devices has become well accepted in health care. However appropriate implementation of these elements has been a challenge for many. Only by implementing these conscious inputs can patient outcomes be improved and health disparities in marginalised groups be addressed.
Australian Health Journal spoke to Gillian Mason, Consumer and Community Involvement Lead at Hunter Medical Research Institute in Newcastle, NSW on this topic discussed at the recent ARCS Conference in Sydney.
-
Role of the Chief Nursing Officer
Professor Alison McMillan PSM spoke with Australian Health Journal about the role of Chief Nursing and Midwifery Officer at the Australian Government Department of Health and Aged Care.
Alison was appointed as our Chief Nursing and Midwifery Officer in November 2019.
In June 2021 Alison was awarded a Public Service Medal for outstanding public service to driving the Government’s national health response priorities during the COVID-19 pandemic, particularly to infection prevention measures.
-
Foundation outlines breast cancer research strategy
Australian Health Journal met with Associate Professor Cleola Anderiesz, CEO of the National Breast Cancer Foundation to hear of the new 5 year Pink Horizon research strategy. Those with lived experience of breast cancer, along with researchers, clinicians, and other funding organisations, have contributed to the development of the foundation’s new five-year Pink Horizon research strategy. This ambitious plan aims to invest $125 million to accelerate research efforts towards the vision of ending deaths from breast cancer.
